Answer
Elocta (efmoroctocog alfa) is contraindicated in patients with hypersensitivity to efmoroctocog alfa or any excipient listed in section 6.1 of its product information.
Sources for this answer
- ELOCTA 250 IU powder and solvent for solution for injectionSwedish Orphan Biovitrum Ltd · emc · SmPC §4.3 Contraindications · Version 11Document updated
Sources checked